Brain pacemaker tested for Musician's hand cramps
NCT ID NCT02911103
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 9 times
Summary
This study tests deep brain stimulation (DBS) surgery for people with severe focal hand dystonia, including musician's dystonia, that hasn't improved with botulinum toxin. Five participants will have electrodes placed in brain areas that control movement, connected to a stimulator in the chest. The goal is to see if DBS is safe and can reduce abnormal hand movements over 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- deep brain stimulation (DBS) surgery
- What this could lead to
- If it works, this could point toward a new treatment option for people with severe focal hand dystonia that hasn't responded to other therapies.
- What could go wrong
- This is a very small, early-phase trial with only 5 participants, so results may not apply to everyone. Brain surgery carries risks like infection, bleeding, or side effects from stimulation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSTONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain stimulation sharpen Decision-Making in Parkinson's?
- Personalized dosing for kids with dystonia? new study investigates genetic factors
- Blood test could spot Parkinson's earlier, study hopes
- Brain implant that thinks for itself tested in Parkinson's and dystonia
- New muscle relaxant drug MTR-601 tested in humans for first time